Analyst Ratings For Alnylam Pharmaceuticals (NASDAQ:ALNY) (NASDAQ:ALNY)
Today, Evercore ISI initiated coverage on Alnylam Pharmaceuticals (NASDAQ:ALNY) (NASDAQ:ALNY) with a In with a price target of $143.00.
Some recent analyst ratings include
- 3/28/2018-Evercore ISI initiated coverage with a In rating.
Recent Insider Trading Activity For Alnylam Pharmaceuticals (NASDAQ:ALNY) (NASDAQ:ALNY)
Alnylam Pharmaceuticals (NASDAQ:ALNY) (NASDAQ:ALNY) has insider ownership of 4.30% and institutional ownership of 92.28%.
- On 3/20/2018 Laurie Keating, SVP, sold 1,562 with an average share price of $149.83 per share and the total transaction amounting to $234,034.46.
- On 3/14/2018 Akshay Vaishnaw, Insider, sold 88,554 with an average share price of $143.10 per share and the total transaction amounting to $12,672,077.40.
- On 3/14/2018 Barry E Greene, President, sold 38,460 with an average share price of $143.10 per share and the total transaction amounting to $5,503,626.00.
- On 3/13/2018 Laurie Keating, SVP, sold 20,000 with an average share price of $145.00 per share and the total transaction amounting to $2,900,000.00.
- On 3/13/2018 Paul Schimmel, Director, sold 27,823 with an average share price of $150.00 per share and the total transaction amounting to $4,173,450.00.
- On 3/9/2018 Philip A Sharp, Director, sold 15,000 with an average share price of $129.00 per share and the total transaction amounting to $1,935,000.00.
- On 1/4/2018 Michael Mason, VP, sold 36,745 with an average share price of $131.59 per share and the total transaction amounting to $4,835,274.55.
Recent Trading Activity for Alnylam Pharmaceuticals (NASDAQ:ALNY) (NASDAQ:ALNY)
Shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) closed the previous trading session at 129.82 down -1.36 1.04% with 126.08000183105469 shares trading hands.